Tzeli Kassiani Allergiologist

Professional Experience

• 2024 to present: Head of Allergology Department, Mitera Private Hospital of Athens

• 2020 to present:  Consultant Allergist, Mitera Private Hospital of Athens

• 2016 to present: Consultant Allergist, Allergology Dep., Athens Naval & Veterans Hospital

• 2013- 2016: Resident Allergist, Allergology Dep., General University Hospital of Athens “Aglaia & Panagiotis Kuriakou”

• Sept 2014 – Nov 2014: Clinical fellow in Allergology and Clinical Immunology, University Hospital of Southampton

• 2011- 2013: Resident in Internal Medicine, 2^nd department, Athens Naval & Veterans Hospital

• 2010 – 2011: Chief Sanitary Officer Supervision, Sanitation Department and Head Diving Medicine Military Unit “Underwater Demolition Command” (D.Y.K.)

• 2009 – 2010: Chief Sanitary Officer Supervision, warship Frigate “Aegean”

• 2007 – 2009: Standard Practice Education as Sanitary Officer of the Navy, Athens Naval & Veterans Hospital: 13 Weeks Pathology, 18 weeks Surgery , 5 weeks Laboratory Division and 24-hours shifts in the Emergency Department (E.D.) of Athens Naval & Veterans Hospital

Membership

• European Academy of Allergy and Clinical Immunology (EAACI)

• Hellenic Society of Allergy and Clinical Immunology ( EEAKA)

• Medical Association of Athens (ΙΣΑ)

Scholarships- Awards

Clinical Fellowship Award from the European Academy and Clinical Immunology (EAACI), project title: “Combined clinical history and sIgE values as predictors of the outcome of food challenge in IgE-mediated food allergy”, Faculty of Medicine, University of Southampton, Southampton General Hospital, NHS

Clinical and Research Interest

• A Phase 3, Randomized, 52-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Adolescent Subjects with Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASTRO)

• A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects with Moderate-to-severe Atopic Dermatitis (AD)

• A Double-blind, Randomized, Active-controlled, Parallel Group, Phase 3 Study to Compare Efficacy and Safety of CT-P39 and Xolair in Patients with Chronic Spontaneous Urticaria Who Remain Symptomatic despite H1-antihistamine Treatment’)

• A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Efficacy and Safety Study of Tezepelumab in Patients with Eosinophilic Esophagitis (CROSSING- a global study).

• A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Three-way Crossover Trial to Evaluate the Efficacy and Safety of Two Dose Levels of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II

• An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema- a global study (HAE)

• Atopic dermatitis – a cross sectional study on disease characteristics and impact on patients/ B7451076 – APOLO (2022-2023)

• “A pilot study to investigate the influence of common viral infections on IgE food sensitivity and IgE reactivity to food allergens”, study protocol in the contex of the european research programme iFAAM (Integrated Approaches to Food Allergen and Allergy  Risk Management) Work package 4/Task 4.8(2013 – 2017

Publications

“A pilot study to investigate the influence of upper respiratory infections on IgE reactivity to food allergens”, P. Xepapadaki, S. Kostoudi, K. Tzeli, N. Kitsioulis, N.G. Papadopoulos Pediatr Allergy Immunol 30: 127-30, 2019.

“Neues Rahmenwerk zur Interpretation von IgE-Tests – eine wissenschaftliche Zusammenfassung”, G. Roberts, M. Ollert, R. Aalberse, M. Austin, A. Custovic, A. DunnGalvin, P. A. Eigenmann, F. Fassio, C. Grattan, P. Hellings, J.Hourihane, E. Knol, A. Muraro, N. Papadopoulos, AF. Santos, S. Schnadt, K. Tzeli . Allergo Journal: interdisziplinäre Zeitschrift für Allergologie und Umweltmedizin: Organ der Deutschen Gesellschaft für Allergie- und Immunitätsforschungli. . 27(5):41-50, 2018.

“A new framework for the interpretation of IgE sensitization tests”,G.Roberts, M. Ollert, R. Aalberse, M. Austin, A. Custovic, A.DunnGalvin, P. A. Eigenmann, Fassio, C. Grattan, P. Hellings, J. Hourihane, E. Knol, A. Muraro, N. Papadopoulos, AF. Santos, S.Schnadt, K. Tzeli, Allergy, 10.1111/all.12939, 71,11,(1540-1551), 2016.

“PD19-Co-recognition of lipid transfer protein in pollen and foods in a Greek pediatric population”, D. Karantoumanis, S. Savvatianos, A. Konstantinopoulos, D. Koutsalitis, A. Pananaki, M.Psomiadou, K. Tzeli, M. Tziotou, D.Mitsias, E. Roumpedaki, S. Giavi, P. Xepapadaki, N. Douladiris, E. Manousakis, N. G. Papadopoulos Clinical and Translational Allergy 4 (Suppl 1), 2014.

“P28-w ell’s syndrome (or Eosinophilic Cellulitis) a case report”, Koutsalitis, D. Karantoumanis, A. Konstantinopoulos, A. Pananaki, M. Psomiadou, K. Tzeli, M. Tziotou, E. Roumpedaki, N.Douladiris, E. Manousakis, N. G. Papadopoulos Clinical and Translational Allergy 4, 2014.

European Poster – Oral presentations

• E-poster, European Academy of Allergy and Clinical Immunology Congress (EAACI), Helsinki, 2017. “A pilot study to investigate the influence of upper respiratory infections on IgE reactivity to  food allergens”,Kostoudi S., Xepapadaki P., Kitsioulis N., Tzeli K., Kokkinou D., Christopoulou G., West P., Manousakis E., Douladiris N., Papadopoulos N.G

• E-poster, European Academy of Allergy and Clinical Immunology Congress (EAACI), Vienna, 2016. “ Tree nut, peanut and almond allergy among children visiting a tertiary hospital in Athens”, Kostoudi S., Douladiris N., Kitsioulis N., Tzeli K., Manolaraki I., Kitsos D., Michopoulou C., Christopoulou G., Zisaki V., Roumpedaki E., Manousakis E., Xepapadaki P., Papadopoulos N.G.

• Oral Presentation, European Academy of Allergy and Clinical Immunology Congress (EAACI), Barcelona, 2015. “Combined clinical history and sIgE values as predictors of the outcome of food challenge in IgE-mediated food allergy”, Tzeli K, Zolkipli ZQ, DunnGalvin A, Erlewyn-Lajeunesse M, Hourihane J, Papadopoulos NG , Blyth T, Roberts

• Ε-Poster, European Academy of Allergy and Clinical Immunology Congress (EAACI), Barcelona, 2015.“ “Retrospective study of oral food challenges performed in children with history of FPIES in a tertiary hospital”, Kostoudi S., Psomiadou M., Tzeli K., Tziotou M., Karantoumanis D., Manolaraki I., Michopoulou C., Georgountzou A., Maggina P., Kyriakakou M., Zisaki V., Georgiou A., Kapoula A., Roumpedaki E., Douladiris N., Manousakis E., Xepapadaki P., Papadopoulos G.

• Ε-Poster, European Academy of Allergy and Clinical Immunology Congress (EAACI), Barcelona, 2015.“Allergy in products of non enzymatic browning reactions-a case report”, Christopoulou , Tziotou M., Psomiadou M., Tzeli K., Karantoumanis D., Kostoudi S., Zisaki V., Georgiou A., Roumpedaki E., Douladiris Ν., Manousakis E., Xepapadaki P., Papadopoulos N.G.

• Ε-Poster, European Academy of Allergy and Clinical Immunology Congress (EAACI), Barcelona, 2015.“Persistent contact urticaria to raw potato in a child with a history of reactivity to ingested cooked potato and high potato- CAP levels: a case report”,

• E-Poster, European Academy of Allergy and Clinical Immunology Congress (EAACI), Copenhagen, 2014.Georgountzou A.,Konstantinou N., Tzeli K., D. Mitsias, Manousakis E., Xepapadaki P., N. Douladiris, Papadopoulos NG. A Rapid Response in the Cold Urticaria Stimulation time Testis associated with anaphylactic Reactions in Children with Cold Urticaria”,